Highest risk patients with clear-cell renal cell carcinoma benefit from adjuvant everolimus
A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell renal ...
A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell renal ...
Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fourth leading cause of cancer-related mortality ...
BRUSSELS; KENILWORTH, N.J., Mar. 17, 2022 – MSD, a trade name of Merck & Co., Inc, Kenilworth, NJ, USA., the ...
Men with microscopic evidence of prostate cancer spreading to their pelvic lymph nodes (LNs) following the surgical resection of the ...
Lugano, Switzerland, 18 September 2021 – The first randomised phase III clinical trial in stage II melanoma has shown a 35% reduction in the risk of recurrence with adjuvant pembrolizumab compared with ...
We bring you the latest science news from best research centers and universities around the world. Check our website.
© 2023 Scienmag- Science Magazine: Latest Science News.
© 2023 Scienmag- Science Magazine: Latest Science News.